Request a document copy: Bharangin, a Diterpenoid Quinonemethide, abolishes constitutive and inducible nuclear factor-kappa B (NF-kappa B) activation by modifying p65 on Cysteine 38 residue and reducing inhibitor of nuclear factor-kappa B alpha Kinase activation, leading to suppression of NF-kappa B-regulated gene expression and sensitization of tumor cells to chemotherapeutic agents

all files (of this document) in restricted access
the file(s) you requested
Cancel